Vitamin B<sub>3</sub> metal-organic frameworks as potential delivery vehicles for therapeutic nitric oxide.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28093365.
- Also identified by DOI 10.1016/j.actbio.2017.01.039.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The synthesis and structural characterization of two isostructural metal (M=Ni, Co) 3D framework structure that integrate vitamin B<sub>3</sub> building blocks with NO delivery capabilities and low toxicity is presented. The compounds with a formula [M<sub>2</sub>(μ<sub>2</sub>-H<sub>2</sub>O)(μ-vitamin B<sub>3</sub>)<sub>4</sub>]·2H<sub>2</sub>O contain two crystallographic distinct divalent metal centres connected by a bridging water and carboxylate group from vitamin B<sub>3</sub>. The porous compounds have the capability of storing and releasing nitric oxide (NO) in a slow and reversible manner, with released amounts of 2.6 and 2.0μmol NOmg<sub>solid</sub><sup>-1</sup>, on the Ni and Co compound, respectively. The NO release followed a convenient slow release kinetic profile in both gas and liquid phases. Haemoglobin tests demonstrated that NO is released to the medium in a biologically active form, thus suitable to trigger the desired response in biological systems. The toxicity of the samples with and without loaded NO was evaluated from cytotoxicity tests in HeLa and HEKn cells, showing low toxicity of the compounds at concentrations below 180μgcm<sup>-3</sup>. The overall results indicate that these bio based MOFs are of interest for therapeutic applications related with NO delivery. STATEMENT OF SIGNIFICANCE.
Medical subject headings
- Drug Delivery Systems
- Metals
- Niacinamide
- Nitric Oxide
- Organic Chemicals